Latest Breaking News On - Covadonga pa - Page 3 : comparemela.com

Altamira Therapeutics (CYTO) Files Second Provisional Patent Application for OligoPhore Nanoparticles Targeting Different KRAS Mutations in Cancer Treatment

Altamira Therapeutics (CYTO) Files Second Provisional Patent Application for OligoPhore Nanoparticles Targeting Different KRAS Mutations in Cancer Treatment
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesCovadonga paCompany oligophoreAmerican cancer societyAltamira therapeutics ltdAltamira therapeuticsUnited states patentTrade officeAltamira therapeutic chief operatingInvestigational new drug

Altamira Therapeutics to Present at 3rd Annual mRNA-Based Therapeutics Summit

08.01.2024 - HAMILTON, BERMUDA , Jan. 08, 2024 (GLOBE NEWSWIRE) - Altamira Therapeutics to Present at 3rd Annual mRNA-Based Therapeutics Summit Altamira’s two flagship programs, AM-401 and AM-411, designed for KRAS-driven cancer and rheumatoid . Seite 1

Covadonga paJw marriott hoteAltamira therapeutics ltdCompany nasdaqBased therapeutics summitChief operating officer

Altamira Therapeutics Provides Business Update and First Half 2023 Financial Results

HAMILTON, BERMUDA, Sept. 12, 2023 Company hosts 1H 2023 Financial Results and Business Update call today at 8 a.m. ET First research collaboration with biopharmaceutical company initiated.

United statesCity ofUnited kingdomThomas meyerCovadonga paMaria grunwaldDelivery technologySecurities exchange commissionSecurities exchangeOsteoarthritis research society international world congressAltamira therapeutics ltdKing college londonWashington university school of medicine stBusiness updateAltamira therapeuticsHeqet therapeutics

Altamira Therapeutics to Host First Half 2023 Financial Results and Business Update Call on September 12th

HAMILTON, BERMUDA , Sept. 06, 2023 Altamira Therapeutics Ltd. , a company dedicated to developing therapeutics that address important unmet medical needs, announced that it will host its First.

Thomas meyerCovadonga paSecurities exchange commissionSecurities exchangeAltamira therapeutics ltdCompany nasdaqFirst halfBusiness update callAltamira therapeutics first halfBusiness updateAccess codeSecurities actSecurities exchange actAnnual report

Altamira Therapeutics to Host First Half 2023 Financial

HAMILTON, BERMUDA , Sept. 06, 2023 (GLOBE NEWSWIRE) Altamira Therapeutics Ltd. (

Covadonga paThomas meyerSecurities exchange commissionAltamira therapeutics ltdCompany nasdaqSecurities exchangeFirst halfBusiness update callAltamira therapeutics first halfBusiness updateAccess codeSecurities actSecurities exchange actAnnual reportNasdaq cytoAltamira therapeutics ltd